In contrast to CD8+ T cells, regulatory T cells, myeloid-derived-suppressor cells, or tumor-associated macrophages inhibit the immune response and are therefore associated with tumor growth and a poor clinical outcome (60, 61). This evidence concerns the gene CD8A and neoplasm.